최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomaterials, v.273, 2021년, pp.120827 -
Park, Hee Ho (Department of Biotechnology and Bioengineering, Kangwon National University) , Kim, Hyelim (College of Pharmacy, Chungnam National University) , Lee, Han Sol (College of Pharmacy, Chungnam National University) , Seo, Eun U (Brain Science Institute, Korea Institute of Science and Technology (KIST)) , Kim, Ji-Eun (College of Pharmacy, Chungnam National University) , Lee, Jee-Hyun (AREZ Co. Ltd.) , Mun, Yong-Hyeon (College of Pharmacy, Chungnam National University) , Yoo, So-Yeol (College of Pharmacy, Chungnam National University) , An, Jiseon (College of Pharmacy, Chungnam National University) , Yun, Mi-Young (Department of Beauty Science, Kwangju Women's University) , Kang, Nae-Won (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National Uni) , Kim, Dae-Duk , Na, Dong Hee , Hong, Kyung Soo , Jang, Jong Geol , Ahn, June Hong , Bae, Jong-Sup , Song, Gyu Yong , Lee, Jae-Young , Kim, Hong Nam , Lee, Wonhwa
Abstract The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a global scale urges prompt and effective countermeasures. Recently, a study has reported that coronavirus disease-19 (COVID-19), the disease caused by SARS-CoV-2 infection, is associated with a decrease in...
1 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 10223 2020 497 506 31986264
2 Vincent J.-L. Taccone F.S. Understanding pathways to death in patients with COVID-19 Lancet Respir Med 8 5 2020 430 432 32272081
3 Danese S. Cecconi M. Spinelli A. Management of IBD during the COVID-19 outbreak: resetting clinical priorities Nat. Rev. Gastroenterol. Hepatol. 17 5 2020 253 255 32214232
4 Jin Y.-H. Cai L. Cheng Z.-S. Cheng H. Deng T. Fan Y.-P. Fang C. Huang D. Huang L.-Q. Huang Q. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res 7 1 2020 4 32029004
5 She J. Jiang J. Ye L. Hu L. Bai C. Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies Clin. Transl. Med. 9 1 2020 1 7 31907669
6 Le T.T. Andreadakis Z. Kumar A. Roman R.G. Tollefsen S. Saville M. Mayhew S. The COVID-19 vaccine development landscape Nat. Rev. Drug Discov. 19 5 2020 305 306 32273591
7 Hong K.S. Lee K.H. Chung J.H. Shin K.-C. Choi E.Y. Jin H.J. Jang J.G. Lee W. Ahn J.H. Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study Yonsei Med. J. 61 5 2020 431 32390367
8 Jang J.G. Hur J. Choi E.Y. Hong K.S. Lee W. Ahn J.H. Prognostic factors for severe coronavirus disease 2019 in Daegu, Korea J. Kor. Med. Sci. 35 23 2020
9 Zhang B. Zhou X. Qiu Y. Feng F. Feng J. Jia Y. Zhu H. Hu K. Liu J. Liu Z. Clinical Characteristics of 82 Death Cases with COVID-19 2020 MedRxiv
10 Zaim S. Chong J.H. Sankaranarayanan V. Harky A. COVID-19 and multiorgan response Curr. Probl. Cardiol. 2020 100618 32439197
11 Lee L.Y. Cazier J.B. Starkey T. Turnbull C. Kerr R. Middleton G. U.C.C.M.P. Team COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Lancet 2020 1919 1926 32473682
12 Mehra M.R. Desai S.S. Kuy S. Henry T.D. Patel A.N. Cardiovascular disease, drug therapy, and mortality in COVID-19 2020 N Engl J Med
13 Shi S. Qin M. Shen B. Cai Y. Liu T. Yang F. Gong W. Liu X. Liang J. Zhao Q. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China JAMA Cardiol 2020 802 810 32211816
14 Russell C.D. Millar J.E. Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Lancet 395 10223 2020 473 475 32043983
15 Geleris J. Sun Y. Platt J. Zucker J. Baldwin M. Hripcsak G. Labella A. Manson D. Kubin C. Barr R.G. Observational study of hydroxychloroquine in hospitalized patients with Covid-19 2020 N Engl J Med
16 Mahase E. Covid-19: what Treatments Are Being Investigated? 2020 BMJ
17 Zheng M. Gao Y. Wang G. Song G. Liu S. Sun D. Xu Y. Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients Cell. Mol. Immunol. 17 5 2020 533 535 32203188
18 Grant W.B. Lahore H. McDonnell S.L. Baggerly C.A. French C.B. Aliano J.L. Bhattoa H.P. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths Nutrients 12 4 2020 988 32252338
19 Riphagen S. Gomez X. Gonzalez-Martinez C. Wilkinson N. Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic Lancet 395 10237 2020 1607 1608 32386565
20 Organization W.H. Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus ( nCoV) Infection Is Suspected: Interim Guidance, 25 January 2020 2020 World Health Organization
21 Delaney J.W. Pinto R. Long J. Lamontagne F. Adhikari N.K. Kumar A. Marshall J.C. Cook D.J. Jouvet P. Ferguson N.D. The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness Crit. Care 20 1 2016 75 27036638
22 Rodrigo C. Leonardi‐Bee J. Nguyen‐Van‐Tam J. Lim W.S. Corticosteroids as adjunctive therapy in the treatment of influenza Cochrane Database Syst. Rev. 3 2016
23 Soy M. Keser G. Atagündüz P. Tabak F. Atagündüz I. Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Clin. Rheumatol. 2020 1
24 Stebbing J. Phelan A. Griffin I. Tucker C. Oechsle O. Smith D. Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments Lancet Infect. Dis. 20 4 2020 400 402 32113509
25 Rojas M. Rodríguez Y. Monsalve D.M. Acosta-Ampudia Y. Camacho B. Gallo J.E. Rojas-Villarraga A. Ramírez-Santana C. Díaz-Coronado J.C. Manrique R. Convalescent plasma in Covid-19: possible mechanisms of action Autoimmun. Rev. 2020 102554 32380316
26 Anderson J. Schauer J. Bryant S. Graves C.R. The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient with Novel Coronavirus 2019 Infection: A Case Report 2020 Case Rep Women's Health e00221
27 Shen C. Wang Z. Zhao F. Yang Y. Li J. Yuan J. Wang F. Li D. Yang M. Xing L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma J. Am. Med. Assoc. 323 16 2020 1582 1589
28 Valk S.J. Piechotta V. Chai K.L. Doree C. Monsef I. Wood E.M. Lamikanra A. Kimber C. McQuilten Z. So-Osman C. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review Cochrane Database Syst. Rev. 5 2020
29 Lam F.W. Cruz M.A. Leung H.-C.E. Parikh K.S. Smith C.W. Rumbaut R.E. Histone induced platelet aggregation is inhibited by normal albumin Thromb. Res. 132 1 2013 69 76 23673386
30 Ekaney M.L. Otto G.P. Sossdorf M. Sponholz C. Boehringer M. Loesche W. Rittirsch D. Wilharm A. Kurzai O. Bauer M. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation Crit. Care 18 5 2014 543 25260379
31 Xu J. Zhang X. Pelayo R. Monestier M. Ammollo C.T. Semeraro F. Taylor F.B. Esmon N.L. Lupu F. Esmon C.T. Extracellular histones are major mediators of death in sepsis Nat. Med. 15 11 2009 1318 1321 19855397
32 Paik S. Choe J.H. Choi G.-E. Kim J.-E. Kim J.-M. Song G.Y. Jo E.-K. Rg6, a rare ginsenoside, inhibits systemic inflammation through the induction of interleukin-10 and microRNA-146a Sci. Rep. 9 1 2019 1 15 30626917
33 Lee W. Ku S.-K. Kim J.-E. Cho S.-H. Song G.-Y. Bae J.-S. Inhibitory effects of protopanaxatriol type ginsenoside fraction (Rgx365) on particulate matter-induced pulmonary injury J. Toxicol. Environ. Health 82 5 2019 338 350
34 Choi Y.H. Han H.-K. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics J Pharm Investig 48 1 2018 43 60
35 Hawkins M.J. Soon-Shiong P. Desai N. Protein nanoparticles as drug carriers in clinical medicine Adv. Drug Deliv. Rev. 60 8 2008 876 885 18423779
36 Chen Q. Liu Z. Albumin carriers for cancer theranostics: a conventional platform with new promise Adv. Mater. 28 47 2016 10557 10566 27111654
37 Chen Q. Wang X. Wang C. Feng L. Li Y. Liu Z. Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy ACS Nano 9 5 2015 5223 5233 25950506
38 Cortes J. Saura C. Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer Eur. J. Canc. 8 1 2010 1 10
39 Chen T.-A. Tsao Y.-C. Chen A. Lo G.-H. Lin C.-K. Yu H.-C. Cheng L.-C. Hsu P.-I. Tsai W.-L. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis Scand. J. Gastroenterol. 44 5 2009 619 625 19191184
40 Ashar H.K. Mueller N.C. Rudd J.M. Snider T.A. Achanta M. Prasanthi M. Pulavendran S. Thomas P.G. Ramachandran A. Malayer J.R. The role of extracellular histones in influenza virus pathogenesis Am. J. Pathol. 188 1 2018 135 148 29107075
41 Høstmark A.T. Tomten S.E. Berg J.E. Serum albumin and blood pressure: a population-based, cross-sectional study J. Hypertens. 23 4 2005 725 730 15775775
42 Singer M. Deutschman C.S. Seymour C.W. Shankar-Hari M. Annane D. Bauer M. Bellomo R. Bernard G.R. Chiche J.-D. Coopersmith C.M. The third international consensus definitions for sepsis and septic shock (Sepsis-3) J. Am. Med. Assoc. 315 8 2016 801 810
43 Hazeldine J. Harris P. Chapple I.L. Grant M. Greenwood H. Livesey A. Sapey E. Lord J.M. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals Aging Cell 13 4 2014 690 698 24779584
44 Xu J. Zhou P. Wang W. Sun A. Guo F. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow J. Mol. Med. 92 1 2014 77 92 24042463
45 Kim J.A. Kim H.N. Im S.K. Chung S. Kang J.Y. Choi N. Collagen-based brain microvasculature model in vitro using three-dimensional printed template Biomicrofluidics 9 2 2015
46 Rittirsch D. Huber-Lang M.S. Flierl M.A. Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture Nat. Protoc. 4 1 2009 31 36 19131954
47 Sun F. Xiao G. Qu Z. Murine bronchoalveolar lavage Bio Protoc 7 10 2017
48 Lee W. Seo J. Kwak S. Park E.J. Na D.H. Kim S. Lee Y.M. Kim I.S. Bae J.S. A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and gamma-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment Adv. Mater. 27 42 2015 6637 6643 26414883
49 Levi M. Thachil J. Iba T. Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19 Lancet Haematol 7 6 2020 e438 32407672
50 Jose R.J. Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation Lancet Respir Med 2020 e46 e47 32353251
51 Barnes B.J. Adrover J.M. Baxter-Stoltzfus A. Borczuk A. Cools-Lartigue J. Crawford J.M. Daßler-Plenker J. Guerci P. Huynh C. Knight J.S. Targeting potential drivers of COVID-19: neutrophil extracellular traps J. Exp. Med. 217 6 2020
52 Tay M.Z. Poh C.M. Rénia L. MacAry P.A. Ng L.F. The trinity of COVID-19: immunity, inflammation and intervention Nat. Rev. Immunol. 2020 1 12 31792373
53 Fyodorov D.V. Zhou B.-R. Skoultchi A.I. Bai Y. Emerging roles of linker histones in regulating chromatin structure and function Nat Rev Mol 19 3 2018 192
54 Barranco-Medina S. Pozzi N. Vogt A.D. Di Cera E. Histone H4 promotes prothrombin autoactivation J. Biol. Chem. 288 50 2013 35749 35757 24178300
55 Lu N.-F. Jiang L. Zhu B. Yang D.-G. Zheng R.-Q. Shao J. Yuan J. Xi X.-M. Elevated plasma histone H4 levels are an important risk factor in the development of septic cardiomyopathy Balkan Med. J. 37 2 2020 72 31674172
56 Vidali S. Morosetti D. Cossu E. Luisi M.L.E. Pancani S. Semeraro V. Consales G. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review ERJ Open Res 6 2 2020
57 Yao Y. Cao J. Wang Q. Shi Q. Liu K. Luo Z. Chen X. Chen S. Yu K. Huang Z. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study J Intensive Care 8 1 2020 1 11 31908779
58 Veras F.P. Pontelli M.C. Silva C.M. Toller-Kawahisa J.E. de Lima M. Nascimento D.C. Schneider A.H. Caetité D. Tavares L.A. Paiva I.M. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology J. Exp. Med. 217 12 2020
59 Skendros P. Mitsios A. Chrysanthopoulou A. Mastellos D.C. Metallidis S. Rafailidis P. Ntinopoulou M. Sertaridou E. Tsironidou V. Tsigalou C. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis J. Clin. Invest. 130 11 2020 6151 6157 32759504
60 Lee Y.Y. Park H.H. Park W. Kim H. Jang J.G. Hong K.S. Lee J.-Y. Seo H.S. Na D.H. Kim T.-H. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm Biomaterials 267 2021 120389 33130319
61 Arcanjo A. Logullo J. Menezes C.C.B. Giangiarulo T.C.d.S.C. Dos Reis M.C. de Castro G.M.M. da Silva Fontes Y. Todeschini A.R. Freire-de-Lima L. Decoté-Ricardo D. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) Sci. Rep. 10 1 2020 1 11 31913322
62 Vulliamy P. Gillespie S. Armstrong P.C. Allan H.E. Warner T.D. Brohi K. Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage Proc. Natl. Acad. Sci. U.S.A. 116 35 2019 17444 17449 31405966
63 Hsieh I.-N. White M. Hoeksema M. Deluna X. Hartshorn K. Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: down-modulation by H4 binding to C-reactive protein and Surfactant protein D PloS One 16 2 2021 e0247605
64 Barbu E.A. Dominical V.M. Mendelsohn L. Thein S.L. Detection and quantification of histone H4 citrullination in early NETosis with image flow cytometry version 4 Front. Immunol. 11 2020 1335 32765493
65 Vasques F. Duscio E. Romitti F. Pasticci I. Caironi P. Meessen J. Latini R. Cressoni M. Camporota L. Pesenti A. Septic shock-3 vs 2: an analysis of the ALBIOS study Crit. Care 22 1 2018 237 30261898
66 Yin L. Dubovetsky D. Louzon-Lynch P. Implementation of an algorithm utilizing saline versus albumin for the treatment of intradialytic hypotension Ann. Pharmacother. 53 2 2019 159 164 30221974
67 Kim D.H. Lee H.S. Kwon T.-W. Han Y.-M. Kang N.-W. Lee M.Y. Kim D.-D. Kim M.G. Lee J.-Y. Single enzyme nanoparticle, an effective tool for enzyme replacement therapy Arch Pharm. Res. (Seoul) 2020 1 21
68 Mehtala J.G. Kulczar C. Lavan M. Knipp G. Wei A. Cys34-PEGylated human serum albumin for drug binding and delivery Bioconjugate Chem. 26 5 2015 941 949
69 Butterfield J.T. Kim H. Knauer D.J. Nevala W.K. Markovic S.N. Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab Sci. Rep. 7 1 2017 1 9 28127051
70 Chen Q. Chen J. Liang C. Feng L. Dong Z. Song X. Song G. Liu Z. Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy J. Contr. Release 263 2017 79 89
71 Suk J.S. Xu Q. Kim N. Hanes J. Ensign L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery Adv. Drug Deliv. Rev. 99 2016 28 51 26456916
72 Schiel J.E. Ohnmacht C.M. Hage D.S. Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling Anal. Chem. 81 11 2009 4320 4333 19422253
73 Daigo K. Takamatsu Y. Hamakubo T. The protective effect against extracellular histones afforded by long-pentraxin PTX3 as a regulator of NETs Front. Immunol. 7 2016 344 27656184
74 Zhou F. Yu T. Du R. Fan G. Liu Y. Liu Z. Xiang J. Wang Y. Song B. Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 1054 1062 32171076
75 Park H.H. Kim H.N. Kim H. Yoo Y. Choi E.Y. Bae J.-S. Lee W. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia Sci Adv 2020 eabc1564 32937590
76 Mehta P. McAuley D.F. Brown M. Sanchez E. Tattersall R.S. Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 395 10229 2020 1033 1034 32192578
77 Liu Q. Zhou Y.-h. Yang Z.-q. The cytokine storm of severe influenza and development of immunomodulatory therapy Cell. Mol. Immunol. 13 1 2016 3 10 26189369
78 Xiao H. Lu M. Lin T.Y. Chen Z. Chen G. Wang W.-C. Marin T. Shentu T.-p. Wen L. Gongol B. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility Circulation 128 6 2013 632 642 23838163
79 Franchi L. Eigenbrod T. Muñoz-Planillo R. Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nat. Immunol. 10 3 2009 241 19221555
80 Namiki M. Kawashima S. Yamashita T. Ozaki M. Hirase T. Ishida T. Inoue N. Hirata K.-i. Matsukawa A. Morishita R. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 22 1 2002 115 120 11788470
81 Kusnadi A. Park S.H. Yuan R. Pannellini T. Giannopoulou E. Oliver D. Lu T. Park-Min K.H. Ivashkiv L.B. The cytokine TNF promotes transcription factor SREBP activity and binding to inflammatory genes to activate macrophages and limit tissue repair Immunity 51 2 2019 241 257 e9 31303399
82 Tang J.J. Li J.G. Qi W. Qiu W.W. Li P.S. Li B.L. Song B.L. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques Cell Metabol. 13 1 2011 44 56
83 Zhang Z. Tang Z. Farokhzad N. Chen T. Tao W. Sensitive, rapid, low-cost, and multiplexed COVID-19 monitoring by the wireless telemedicine platform Matter 3 6 2020 1818 1820 33289009
84 Tang Z. Zhang X. Shu Y. Guo M. Zhang H. Tao W. Insights from nanotechnology in COVID-19 treatment Nano Today 36 2021 101019 33178330
85 Tang Z. Kong N. Zhang X. Liu Y. Hu P. Mou S. Liljeström P. Shi J. Tan W. Kim J.S. A materials-science perspective on tackling COVID-19 Nat Rev Mater 5 11 2020 847 860 33078077
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.